Facilitating communication between embryo and endometrium
EmbryoGen and BlastGen comprise the world‘s first media suite containing the recombinant human
GM-CSF cytokine, for cleavage stage and blastocyst stage embryos. These unique products aim to reduce stress caused to the embryo by creating a more physiological in vitro environment, improving the outcome of a successful implantation.
Recommended for patients who have experienced:
- Recurrent clinical and biochemical pregnancy loss
- Recurrent implantation failure
- Unexplained infertility
Use EmbryoGen for cleavage-stage embryos followed by BlastGen for blastocyst-stage embryos.
This product is available for sale in the U.S.A and selected countries in Europe and the rest of the world.
Please always contact your local ORIGIO representative to confirm local availability.